Ignite Creation Date:
2025-12-24 @ 11:44 PM
Ignite Modification Date:
2025-12-25 @ 9:37 PM
Study NCT ID:
NCT04849351
Status:
COMPLETED
Last Update Posted:
2025-04-06
First Post:
2021-04-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Clinical Study of HMPL-689 for Relapsed/Refractory Marginal Zone Lymphoma and Follicular Lymphoma
Sponsor:
Hutchison Medipharma Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-02-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-02-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-04-13
First Submit QC Date:
None
Study First Post Date:
2021-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-06
Last Update Post Date Type:
ACTUAL